Optic atrophy after sildenafil use

Optometry. 2007 Jul;78(7):329; author reply 329-30. doi: 10.1016/j.optm.2007.05.005.
No abstract available

Publication types

  • Case Reports
  • Comment
  • Letter

MeSH terms

  • 3',5'-Cyclic-GMP Phosphodiesterases / antagonists & inhibitors
  • Aged
  • Glaucoma, Open-Angle / drug therapy
  • Humans
  • Male
  • Optic Atrophy / chemically induced*
  • Optic Atrophy / pathology
  • Optic Nerve / drug effects
  • Optic Nerve / pathology
  • Phosphodiesterase Inhibitors / adverse effects*
  • Phosphodiesterase Inhibitors / therapeutic use
  • Piperazines / adverse effects*
  • Piperazines / therapeutic use
  • Purines / adverse effects
  • Purines / therapeutic use
  • Sildenafil Citrate
  • Sulfones / adverse effects*
  • Sulfones / therapeutic use

Substances

  • Phosphodiesterase Inhibitors
  • Piperazines
  • Purines
  • Sulfones
  • Sildenafil Citrate
  • 3',5'-Cyclic-GMP Phosphodiesterases